Oppenheimer & Co. Inc. Buys New Holdings in athenahealth (ATHN)

Oppenheimer & Co. Inc. bought a new position in athenahealth (NASDAQ:ATHN) during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 2,203 shares of the health services provider’s stock, valued at approximately $315,000.

Several other hedge funds have also recently modified their holdings of ATHN. Allianz Asset Management GmbH increased its stake in athenahealth by 67.0% during the fourth quarter. Allianz Asset Management GmbH now owns 555,766 shares of the health services provider’s stock worth $73,939,000 after acquiring an additional 223,006 shares during the last quarter. ARK Investment Management LLC increased its stake in athenahealth by 55.5% during the fourth quarter. ARK Investment Management LLC now owns 379,439 shares of the health services provider’s stock worth $50,481,000 after acquiring an additional 135,383 shares during the last quarter. Sumitomo Mitsui Asset Management Company LTD increased its stake in athenahealth by 40.3% during the fourth quarter. Sumitomo Mitsui Asset Management Company LTD now owns 454,160 shares of the health services provider’s stock worth $60,421,000 after acquiring an additional 130,545 shares during the last quarter. ArrowMark Colorado Holdings LLC increased its stake in athenahealth by 30.1% during the fourth quarter. ArrowMark Colorado Holdings LLC now owns 511,863 shares of the health services provider’s stock worth $68,098,000 after acquiring an additional 118,411 shares during the last quarter. Finally, Ascend Capital LLC bought a new stake in athenahealth during the fourth quarter worth approximately $11,382,000.

Shares of athenahealth opened at $149.43 on Friday, according to MarketBeat. The company has a quick ratio of 2.71, a current ratio of 2.71 and a debt-to-equity ratio of 0.25. The company has a market capitalization of $6.00 billion, a P/E ratio of 57.59, a PEG ratio of 2.76 and a beta of 1.16. athenahealth has a 52-week low of $147.02 and a 52-week high of $149.87.

athenahealth (NASDAQ:ATHN) last announced its quarterly earnings results on Thursday, April 26th. The health services provider reported $1.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.72 by $0.53. The firm had revenue of $329.40 million during the quarter, compared to analyst estimates of $318.13 million. athenahealth had a return on equity of 13.01% and a net margin of 6.77%. athenahealth’s quarterly revenue was up 15.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.32 earnings per share. analysts anticipate that athenahealth will post 2.92 EPS for the current year.

Several brokerages have weighed in on ATHN. ValuEngine raised athenahealth from a “hold” rating to a “buy” rating in a research note on Tuesday, May 8th. Cantor Fitzgerald reissued a “hold” rating and set a $140.00 price objective on shares of athenahealth in a research note on Monday. Berenberg Bank cut athenahealth from a “buy” rating to a “hold” rating and boosted their price objective for the stock from $143.00 to $163.00 in a research note on Tuesday. Jefferies Group set a $160.00 target price on athenahealth and gave the company a “hold” rating in a research note on Thursday. Finally, Royal Bank of Canada set a $160.00 target price on athenahealth and gave the company a “hold” rating in a research note on Thursday. One research analyst has rated the stock with a sell rating, seventeen have given a hold rating and nine have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $151.35.

In related news, CMO Timothy John O’brien sold 3,064 shares of the business’s stock in a transaction that occurred on Friday, March 2nd. The stock was sold at an average price of $137.27, for a total value of $420,595.28. Following the completion of the sale, the chief marketing officer now owns 11,320 shares in the company, valued at $1,553,896.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Bradford Kyle Armbrester sold 2,235 shares of the company’s stock in a transaction on Friday, March 2nd. The stock was sold at an average price of $138.70, for a total value of $309,994.50. Following the sale, the senior vice president now owns 10,146 shares of the company’s stock, valued at approximately $1,407,250.20. The disclosure for this sale can be found here. Insiders sold 48,431 shares of company stock valued at $7,084,565 in the last quarter. 2.90% of the stock is owned by company insiders.

athenahealth Company Profile

athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.

Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth (NASDAQ:ATHN).

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Aecon Group’s  “Outperform Overweight” Rating Reiterated at National Bank Financial
Aecon Group’s “Outperform Overweight” Rating Reiterated at National Bank Financial
Friendz Price Reaches $0.0195
Friendz Price Reaches $0.0195
Head-To-Head Review: Fortive  versus Hurco Companies
Head-To-Head Review: Fortive versus Hurco Companies
Civic Achieves Market Capitalization of $110.16 Million
Civic Achieves Market Capitalization of $110.16 Million
SG Americas Securities LLC Has $958,000 Stake in Jabil Inc
SG Americas Securities LLC Has $958,000 Stake in Jabil Inc
SG Americas Securities LLC Purchases 30,004 Shares of Nutrisystem
SG Americas Securities LLC Purchases 30,004 Shares of Nutrisystem


Leave a Reply

 
© 2006-2018 Zolmax.